On August 10, 2016, Jeffrey Spees, PH.D., associate professor in the Division of Cardiovascular Medicine, was featured in a story on WCAX-TV regarding the drug therapy he’s developing, called VasaPlex, that has been shown in animal models to help reduce heart damage following a heart attack.
